The private-lab testing that overcomes import detentions and builds the evidence to petition off an Import Alert red list — coordinated end-to-end.
| Overcome a detention | Removal from DWPE | |
|---|---|---|
| Goal | Release one specific shipment | Stop the automatic detentions (green list) |
| Evidence | Private-lab analysis showing that shipment is admissible | Petition + a run of consecutive non-violative entries |
| Result | Shipment may release — but you stay on the red list | Firm/product removed from the red list |
| Scope | Per shipment | Root cause + CAPA + 5 (or more) consecutive entries |
Since December 1, 2024, private-laboratory testing submitted to support release from DWPE or removal from an import alert for FDA-regulated food must be conducted by a LAAF-accredited laboratory (Laboratory Accreditation for Analyses of Foods).
DWPE sampling and testing coordination is handled by our partner FDA Detention Sampling — a specialist focused specifically on import-detention sampling and private-laboratory testing coordination. They coordinate the sampling, the accredited laboratory, the run of consecutive entries, and the analytical documentation that supports overcoming detentions and petitioning for removal from an import alert red list.
If your product is on an Import Alert red list and you need the private-laboratory sampling and testing coordinated — to overcome detentions and build a removal petition — contact our partner FDA Detention Sampling. They specialize in DWPE detention sampling and testing coordination end-to-end.
fdadetentionsampling.com · info@fdadetentionsampling.com · +1-786-561-3726 (WhatsApp). For the underlying rules, see FDA Registration Assistance's DWPE and import-alert removal guides.
When your product is on an Import Alert red list, FDA subjects it to Detention Without Physical Examination (DWPE) - every matching shipment is detained without inspection, and the burden shifts to you to prove admissibility. Private-laboratory sampling and testing is how you meet that burden: it produces the analytical evidence to (1) overcome an individual detention and get a specific shipment released, and (2) build the record of consecutive compliant entries needed to petition for removal from the red list. Coordinating that testing is a specialized process.
First, overcoming an individual detention: you submit private-laboratory analysis showing a specific detained shipment is admissible, to the FDA compliance office named in the notice of detention. If accepted, that shipment may be released - but you remain on the red list, and future shipments keep getting detained. Second, removal from DWPE: a separate petition, supported by evidence that the underlying problem is resolved plus a run of consecutive compliant entries, to get the firm/product off the red list (onto the green list). The testing supports both.
It depends on the specific import alert, but a common standard is a minimum of five (5) consecutive commercial import entries that FDA released based on non-violative private-laboratory analyses. Some alerts require more - for example, certain agricultural-product alerts call for twelve (12) consecutive non-violative shipments. They must be normal commercial containers; you can't split one container into smaller shipments to reach the count faster. Confirm the exact requirement in your specific alert.
Yes. All analytical findings must be submitted to FDA regardless of the results - you can't run tests and submit only the passing ones. FDA also may, at its discretion, collect and analyze its own audit samples before making a final admissibility decision. This is why cutting corners on sampling or testing backfires: incomplete or selectively reported data, or results that don't hold up to an FDA audit sample, can derail a detention response or a removal petition.
For food, yes - and this is a recent change. As of December 1, 2024, private-laboratory testing submitted to support release from DWPE or removal from an import alert for FDA-regulated food must be conducted by a LAAF-accredited laboratory (Laboratory Accreditation for Analyses of Foods). For other product types, testing must follow FDA's private-laboratory analytical-package requirements and be from a laboratory whose data FDA will accept. Choosing the right, accepted laboratory is a critical part of the coordination.
It's the documented sampling and analytical record FDA expects with private-lab results - covering sample collection, chain of custody, the methods used, the analyst and laboratory information, the raw data and results, and supporting records - following FDA's private-laboratory analytical-package procedures (ORA Lab Manual). A complete, properly assembled package is what lets FDA rely on the private results; a weak or incomplete package is a common reason detentions and petitions stall.
It's the end-to-end management of the testing process: reading the specific import alert and notice of detention to determine what must be tested and to what standard; designing the sampling protocol; selecting an accepted laboratory (LAAF-accredited for food); coordinating the sampling of each detained/commercial entry; managing the run of consecutive entries; assembling the Private Laboratory Analytical Packages; and organizing the analytical evidence for the individual detentions and for the removal petition. It ties the lab work to the regulatory strategy.
DWPE sampling and testing coordination is handled by our partner, FDA Detention Sampling, a specialist focused specifically on import-detention sampling and private-laboratory testing coordination. You can reach them at info@fdadetentionsampling.com or +1-786-561-3726 (also available on WhatsApp), or at fdadetentionsampling.com. They coordinate the sampling, the accredited laboratory, the consecutive entries, and the analytical documentation that supports overcoming detentions and petitioning for removal.
No - and be wary of anyone who promises that. Removal from DWPE is at FDA's discretion. Even a complete run of compliant, well-documented entries plus a strong petition (root cause, corrective and preventive actions) is reviewed by FDA, which may take audit samples before deciding. Good sampling and testing coordination gives you the strongest possible evidence, but it can't guarantee FDA's decision or a specific timeline. What it does is make sure the evidence is done right so it isn't the reason for a denial or delay.
It varies and is outside anyone's control, because it depends on the run of consecutive entries (each shipment must arrive, be sampled, tested, and released) and on FDA's review of the petition. For food with a strong, complete petition, the overall process commonly takes several months and can run up to about a year. Because each compliant entry takes time to clear and FDA review adds more, no firm can honestly promise a fixed removal date - plan for a multi-month process.
You can attempt to bring in shipments, but each one will be detained under DWPE and will only be released if you overcome the detention with acceptable evidence (typically private-lab analysis) for that specific shipment - which is costly and slow per shipment. Building the consecutive-entry record for removal is essentially doing this repeatedly while assembling the petition. Some firms pause or limit shipments during the process; the coordination helps sequence the entries needed for the petition.
DWPE and import alerts apply across FDA-regulated products - food, dietary supplements, drugs, devices, and cosmetics can all be subject to DWPE. The testing that's relevant depends on the violation cited in the alert (e.g., pathogens, pesticide residues, decomposition, filth, adulteration, labeling). The food LAAF-accreditation requirement is specific to food; other product types follow FDA's private-laboratory requirements. The coordination is tailored to the product and the specific alert/violation.
Overcoming a detention releases one specific shipment - you prove that shipment is admissible - but you stay on the red list and the next shipment is detained again. Removal from DWPE (adding the firm/product to the green list) is the goal: it stops the automatic detentions going forward. Removal requires a petition showing the root problem is fixed plus the consecutive-entry evidence. Many companies release a shipment or two and mistakenly think they're "off" - they're not until the petition is granted.
Using a laboratory FDA won't accept (for food, not LAAF-accredited since Dec 1, 2024); submitting only passing results (all results must go to FDA); splitting one container to reach the entry count faster; an incomplete analytical package; treating a released shipment as "removal" from the list; testing for the wrong analytes for the cited violation; and no root-cause/corrective-action record to accompany the testing in the petition. Each can stall or sink a detention response or removal petition.
It's most urgent for firms already on a red list, but it also matters if you've received a notice of detention (even before formal listing) or expect scrutiny. Overcoming detentions and, ultimately, petitioning for removal both rely on properly coordinated sampling and testing. If you're not yet detained, strong upstream compliance (for food, FSVP and supplier controls) is the best way to avoid DWPE in the first place - see the related guides.
FDA Registration Assistance handles FDA registration and broader compliance, and refers DWPE sampling and testing coordination to our partner FDA Detention Sampling, which specializes in it. If your product is on an import alert red list and you need the private-laboratory sampling and testing coordinated - to overcome detentions and build a removal petition - contact FDA Detention Sampling at info@fdadetentionsampling.com or +1-786-561-3726 (WhatsApp), or visit fdadetentionsampling.com. For the underlying rules, see our DWPE and Import Alert removal guides.